Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Healer

Douglas Scherr

Surgeons and Perioperative Specialists

Douglas S. Scherr, born on 7 January 1967, is an American surgeon who specializes in urologic oncology, the surgical and medical care of cancers of the urinary and male reproductive systems. He serves as Clinical Director of Urologic Oncology at NewYork-Presbyterian and Weill Cornell Medicine and holds a visiting appointment at the Rockefeller University. A native of New York, he studied government at Cornell University, spent a year in Shenyang, China, trained in medicine at the George Washington University School of Medicine, completed a six-year urology residency at New York-Presbyterian Hospital and then a two-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center. He is described as the first physician at Cornell to perform a robotic prostatectomy and a robotic cystectomy, and his clinical focus covers prostate, bladder, kidney and testicular cancers and sarcomas of the genitourinary tract and retroperitoneum. His laboratory work has addressed the hormonal regulation of bladder cancer and the use of the innate immune system against urologic tumors, and he has patented a laser-based approach called multiphoton endoscopy for imaging tissue at the microscopic level. This entry records what is publicly stated about his career and gives no medical advice.

Facts
Birth Year
1967 1
Connections

Specialist In

Source Douglas Scherr (source article)
Source Douglas Scherr (source article)
In the Other Atlases

Nationality

Also in Geography Atlas: the nationality of this subject.

Source Douglas Scherr (source article)Lead, nationality
Quote, Lead, nationality
is an American surgeon
Sources
1. Douglas Scherr (source article)
  • Lead, birth date
    born January 7, 1967
  • Lead, nationality
    is an American surgeon
  • Specialist In: Urology, Lead, specialty
    specialist in Urologic Oncology
  • Specialist In: Oncology, Lead, specialty
    specialist in Urologic Oncology
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.